[go: up one dir, main page]

AU2003289894A1 - Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4) - Google Patents

Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4)

Info

Publication number
AU2003289894A1
AU2003289894A1 AU2003289894A AU2003289894A AU2003289894A1 AU 2003289894 A1 AU2003289894 A1 AU 2003289894A1 AU 2003289894 A AU2003289894 A AU 2003289894A AU 2003289894 A AU2003289894 A AU 2003289894A AU 2003289894 A1 AU2003289894 A1 AU 2003289894A1
Authority
AU
Australia
Prior art keywords
pde9a4
therapeutics
diagnostics
diseases associated
human phosphodiesterase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003289894A
Inventor
Ulf Bruggemeier
Stefan Golz
Holger Summer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2003289894A1 publication Critical patent/AU2003289894A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003289894A 2002-12-09 2003-11-26 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4) Abandoned AU2003289894A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027529 2002-12-09
EP02027529.3 2002-12-09
PCT/EP2003/013277 WO2004053493A1 (en) 2002-12-09 2003-11-26 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4)

Publications (1)

Publication Number Publication Date
AU2003289894A1 true AU2003289894A1 (en) 2004-06-30

Family

ID=32479715

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003289894A Abandoned AU2003289894A1 (en) 2002-12-09 2003-11-26 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4)

Country Status (3)

Country Link
EP (1) EP1576372A1 (en)
AU (1) AU2003289894A1 (en)
WO (1) WO2004053493A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100113484A1 (en) * 2006-12-13 2010-05-06 Aska Pharmaceutical Co., Ltd. Treating agent of uropathy
KR101695866B1 (en) * 2009-05-12 2017-01-13 코닌클리케 필립스 엔.브이. Phosphodiesterase 9a as prostate cancer marker

Also Published As

Publication number Publication date
WO2004053493A1 (en) 2004-06-24
EP1576372A1 (en) 2005-09-21

Similar Documents

Publication Publication Date Title
AU2003251471A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5)
AU2003301894A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d)
AU2003276220A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a)
AU2003229735A1 (en) Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
AU2003276136A1 (en) Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1)
AU2003289894A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4)
AU2003283303A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)
AU2003283427A1 (en) Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
AU2003205627A1 (en) Diagnostics and therapeutics for diseases associated with gpr72
AU2003294728A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)
AU2003279361A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b)
AU2003267380A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a)
AU2003288171A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3)
AU2003274083A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a)
AU2003279323A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b)
AU2003288158A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c)
AU2003250221A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 6(cxcr6)
AU2003282087A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1)
AU2003279322A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3)
AU2003276187A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a)
AU2003283302A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1)
AU2003301913A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2)
AU2003274082A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a)
AU2003229736A1 (en) Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)
AU2003245981A1 (en) Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase